Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03874728
Other study ID # 4151
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 20, 2019
Est. completion date March 1, 2020

Study information

Verified date July 2020
Source University of Liverpool
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A third of people over 65, and half of people over 80, fall at least once a year. Falls are the most common cause of death from injury in the over 65s and result in a significant financial burden on the whole society. Shoes directly influence balance, gait, and the subsequent risk of slips, trips and falls by altering somatosensory feedback to the foot and ankle. Minimal shoes, that is shoes lacking a firm heel cup, a rigid sole or longitudinal arch support, have shown advantages in strengthening muscles and improving balance as compared to conventional shoes. However, limited research has studied the effect of minimal shoe in older people at risk of falls. The aim of the project will be to assess the effects of minimal shoes in older people at risk of falls, compared to conventional shoes and barefoot.


Description:

Study participants will attend a one-day testing session at the Movement Laboratory, University of Liverpool. Participants will be subjected to several standing and walking tests while wearing three types of footwear in a randomised order: (i) a minimal shoe, (ii) a conventional shoe, and (iii) barefoot. Participants' physical function, stability during standing and walking and an activity of lower leg muscles will be assessed in each of those three footwear conditions. Participants will also be asked about perceptions of footwear, regarding a minimal shoe and a conventional shoe. At the end of assessments, participants will be asked to complete several walking bouts while wearing a minimal shoe with "smart" shoe insoles, to determine "smart" insoles' validity in obtaining gait characteristics against a gold standard measure. Finally, those participants who volunteer to take part in a two-week follow-up study, will be asked to wear the minimal shoes with "smart" insoles during daily life for two weeks, After two weeks, they will be asked to fill in an online questionnaire asking them about total time they used the minimal shoes and insoles and about how satisfied they were with them.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date March 1, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

- Age: = 60 years old

- One of the vulnerability criteria for risk falls:

(i) = 1 self-reported falls after the age of 60; (ii) balance impairment as indicated by a score <45 on the Berg Balance Scale, by a score >2 on the simplified Tinetti Gait & Balance test or via any other validated and reliable clinical instrument used at the recruitment site; (iii) one or two criteria for physical frailty

Exclusion Criteria:

- Macro-vascular symptoms (angina, stroke or a peripheral vascular disease)

- Neuromuscular diseases (Multiple Sclerosis, Alzheimer Disease or Parkinson Disease)

- Diabetes

- Use of a walking aid (cane or walker)

- Ankle, knee, hip surgery = 3 months

- Pain in the lower extremities of = 8 on the numeric rating scale

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Minimal shoes
A minimal shoe (Vivobarefoot Ltd., London, UK) will be used.
Standardised conventional shoes
The Go Walk 4.0-Pursuit shoe for women (Skechers USA, Inc.) and the Superior 2.0-Jeveno shoe for men (Skechers USA, Inc) will be used.
Barefoot
Participants will conduct the assessments barefoot.
"Smart" shoe insoles
Arion pressure-measuring insoles (Eindhoven, The Netherlands) will be used in the study.

Locations

Country Name City State
United Kingdom University of Liverpool Liverpool Merseyside

Sponsors (2)

Lead Sponsor Collaborator
University of Liverpool Liverpool University Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Timed Up and Go test Time (in seconds) to complete the Timed Up and Go test First day of joining the study
Primary Star Excursion Balance Test Reach (in centimetres) to achieve during the Star Excursion Balance Test First day of joining the study
Primary Postural stability Anterior-Posterior and latero-medial movement (in centimetres) of the centre of pressure First day of joining the study
Primary Dynamic stability Variability (standard deviations) of spatio-temporal gait characteristics First day of joining the study
Primary Muscle activity Electromyography activity for selected lower leg muscles and expressed in millivolts First day of joining the study
Primary Perceived attractiveness Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive" and 100 mm being "extremely attractive" First day of joining the study
Primary Perceived attractiveness for others Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive for others" and 100 mm being "extremely attractive for others" First day of joining the study
Primary Perceived comfort Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely uncomfortable" and 100 mm being "extremely comfortable" First day of joining the study
Primary Perceived weight Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely light" and 100 mm being "extremely heavy" First day of joining the study
Primary Perceived fit Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "poorest fit possible" and 100 mm being "best fit possible" First day of joining the study
Primary Perceived ease of use Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "most difficult as possible" and 100 mm being "as easy as imaginable" First day of joining the study
Primary Perceived stability Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unstable" and 100 mm being "extremely stable" First day of joining the study
Secondary Validity of "smart" shoe insoles Validity of Arion insoles against Qualisys Motion Capture System First day of joining the study
Secondary Adherence to wearing minimal shoes in daily life Adherence to wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed in total time in days and hours The assessment will be performed at 2 weeks
Secondary Satisfaction of wearing minimal shoes in daily life Satisfaction of wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed on a 5-point Likert scale, with the following levels: 1 - Very dissatisfied, 2 - dissatisfied, 3 - unsure, 4 - satisfied, 5 - Very satisfied. The assessment will be performed at 2 weeks
Secondary Gait characteristics during daily life Gait characteristics, assessed with "smart" shoe insoles, during activities of daily life and expressed in spatio-temporal metrics The assessment will be performed at 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A